HOOD Misses Out on Joining the S&P 500: What This Means for Investors — Positive
HOOD Zacks Investment Research — June 10, 2025Robinhood's S&P 500 snub halts its six-day rally, triggering a sharp dip and raising questions about its valuation and momentum.

Kuehn Law Encourages Investors of ModivCare, Inc. to Contact Law Firm — Neutral
MODV PRNewsWire — June 10, 2025NEW YORK , June 10, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of ModivCare, Inc. (NASDAQ: MODV) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at ModivCare caused the company to misrepresent or fail to disclose that certain contracts used in ModivCare's non-emergency medical transportation ("NEMT") segment caused the Company's free cash flow to deteriorate and that, as a result, (1) contract renegotiations and pricing accommodations negatively impacted the Company's adjusted EBITDA; (2) the Company had insufficient liquidity; and (3) positive statements about the …

At WWDC 2025, Apple sang developers' praises amid AI letdowns and App Store battles — Neutral
AAPL TechCrunch — June 10, 2025At the end of the WWDC 2025 keynote address on Monday, the company literally sang its praises to app developers, as singer-songwriter Allen White humorously turned customers' positive App Store reviews into song lyrics for a tune titled “6 out of 5 stars.”

Frozen Food Gains Momentum: Is NOMD Poised to Lead the Pack? — Positive
NOMD Zacks Investment Research — June 10, 2025Nomad Foods leverages the growing trends in savory frozen foods to command a strong leadership position.

Kuehn Law Encourages Investors of Integral Ad Science Holding Corp. to Contact Law Firm — Neutral
IAS PRNewsWire — June 10, 2025NEW YORK , June 10, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Integral Ad Science Holding Corp. (NASDAQ: IAS) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Integral Ad Science caused the company to misrepresent or fail to disclose that (i) that IAS was experiencing a new material trend of increased competitive pricing pressures and that, as a result, IAS had been forced to cut prices to compensate for weakening demand and slowing revenue growth; (ii) that IAS's pricing function was no …

Designer Brands Inc. (DBI) Q1 2025 Earnings Call Transcript — Neutral
DBI Seeking Alpha — June 10, 2025Designer Brands Inc. (NYSE:DBI ) Q1 2025 Earnings Conference Call June 10, 2025 8:30 AM ET Company Participants Douglas M. Howe - CEO & Director Jared A.

First BanCorp to Announce 2Q 2025 Results on July 22, 2025 — Neutral
FBP Business Wire — June 10, 2025SAN JUAN, Puerto Rico--(BUSINESS WIRE)--First BanCorp (the “Corporation”) (NYSE: FBP), the bank holding company for FirstBank Puerto Rico, announced today that it expects to report its financial results for the second quarter ended June 30, 2025, before the market opens on July 22, 2025. First BanCorp will hold a conference call and live webcast to discuss the financial results at 10:00am Eastern Time on Tuesday, July 22, 2025. The call and webcast will be broadcast live over the internet and c.

Papa Johns Launches Its First-Ever Croissant Pizza, Giving Pizza Lovers Their Flakiest Bite Ever — Neutral
PZZA Business Wire — June 10, 2025DUBAI, United Arab Emirates--(BUSINESS WIRE)--Papa Johns is elevating the pizza experience with the global launch of its latest innovation: the all-new Croissant Pizza. The Croissant Pizza indulgently pairs the delicate, flaky texture of a buttery croissant with the bold flavors of Papa Johns pizza – bringing the brand's Better Ingredients. Better Pizza.® promise to life through craft, quality and innovation. A pizza this expertly crafted deserves to be delivered in cutting-edge artistic style.

iOS is getting its biggest redesign in more than a decade. Transcript: Apple's annual World Wide Developers Conference has officially kicked off and while nothing jaw-dropping has been unveiled - the company did make a few waves.

Has SFM's 12% EBITDA Margin Set a New Long-Term Benchmark? — Positive
SFM Zacks Investment Research — June 10, 2025SFM posts an 11.8% EBITDA margin in Q1 2025 as store optimization, private labels and self-distribution drive gains.

Core & Main (CNM) Matches Q1 Earnings Estimates — Positive
CNM Zacks Investment Research — June 10, 2025Core & Main (CNM) came out with quarterly earnings of $0.52 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.49 per share a year ago.

Designer Brands (DBI) Reports Q1 Loss, Misses Revenue Estimates — Negative
DBI Zacks Investment Research — June 10, 2025Designer Brands (DBI) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of $0.01. This compares to earnings of $0.08 per share a year ago.

United Natural Foods (UNFI) Beats Q3 Earnings and Revenue Estimates — Positive
UNFI Zacks Investment Research — June 10, 2025United Natural Foods (UNFI) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.10 per share a year ago.

Academy Sports and Outdoors, Inc. (ASO) Lags Q1 Earnings and Revenue Estimates — Negative
ASO Zacks Investment Research — June 10, 2025Academy Sports and Outdoors, Inc. (ASO) came out with quarterly earnings of $0.76 per share, missing the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $1.08 per share a year ago.

Kuehn Law Encourages Investors of Actinium Pharmaceuticals, Inc. to Contact Law Firm — Neutral
ATNM PRNewsWire — June 10, 2025NEW YORK , June 10, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Actinium Pharmaceuticals, Inc. (NYSE: ATNM) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Actinium Pharmaceuticals caused the company to misrepresent or fail to disclose that (1) the Company's data from the Sierra Trial was unlikely to satisfy the FDA's guidelines for the acceptance and approval of Iomab-B BLA; (2) the additional analyses, including long-term follow-ups that purportedly demonstrated a trend towards improved Overall Survival that the Company provided to the …

Micron: Why The Stock Is Rising, And Where It's Going Next — Positive
MU Seeking Alpha — June 10, 2025Micron Technology, Inc. stock has risen 80% off recent lows. With a NAND price recovery on the horizon, investors are betting on a strong Q4 2025 and FY2026. Continued strength in DRAM and an inflection in NAND pricing has MU stock set up for its best year yet.

eToro beats estimates for first quarter as public company — Positive
ETOR Proactive Investors — June 10, 2025eToro Group Ltd shares fell on Tuesday morning as marketing and growth investments hit its profits during its first quarter as a publicly traded company. The company's income fell to $60 million from $64 million in the year-ago period, attributed to increased investment in marketing and growth.

Utilities Go Green: Will Strengthening Renewable Focus Benefit NEE? — Positive
NEE Zacks Investment Research — June 10, 2025NextEra's early bet on renewables and strong battery storage push position it to ride the clean energy transition profitably.

ITRI to Roll Out Cyble 5 in APAC to Boost Water Utilities' Operations — Positive
ITRI Zacks Investment Research — June 10, 2025Itron will launch its leak-detecting Cyble 5 module in Asia-Pacific to modernize water metering and boost sustainability.

Recover Investment Losses: Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST) — Neutral
WST Accesswire — June 10, 2025NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=152449&wire=1&utm_campaign=24 or contact Joseph E. Levi, Esq.
